SRE
63
-3
LH
42
2
MCO
73
3
MRO
55
3
TGNA
53
2
VLO
40
-2
TGT
25
-24
OXY
40
3
DVA
72
2
DAL
80
-4
KR
34
-3
HAS
30
2
QRVO
6
2
HON
65
-2
L
62
2
PBI
60
-5
PSA
51
-4
EXPE
88
2
MUR
43
3
COP
56
2
SRE
63
-3
LH
42
2
MCO
73
3
MRO
55
3
TGNA
53
2
VLO
40
-2
TGT
25
-24
OXY
40
3
DVA
72
2
DAL
80
-4
KR
34
-3
HAS
30
2
QRVO
6
2
HON
65
-2
L
62
2
PBI
60
-5
PSA
51
-4
EXPE
88
2
MUR
43
3
COP
56
2
Financhill
Back

Dianthus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
1

DNTH
Dianthus Therapeutics

Last Price:
20.87
Seasonality Move:
12.89%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
248.79
Seasonality Move:
10.85%
Sell
1
Dianthus Therapeutics (DNTH) is a Sell

Is Dianthus Therapeutics a Buy, Sell or Hold?

  • The current Dianthus Therapeutics [DNTH] share price is $20.77. The Score for DNTH is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • DNTH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNTH Stock Price Chart

What is Dianthus Therapeutics's stock price today?

  • The Dianthus Therapeutics share price today is $20.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNTH is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $248.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

DNTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.34 Sell
Relative Strength Index (14 RSI): 23.86 Sell
Chaikin Money Flow: -146216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.88 - 29.38) Sell
Bollinger Bands (100): (26.17 - 29.09) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.64 Sell
Relative Strength Index (14 RSI): 39.68 Sell
Chaikin Money Flow: 997085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (254.01 - 292.55) Sell
Bollinger Bands (100): (248.69 - 281.73) Sell

DNTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.66 Sell
20-day SMA: 26.9 Sell
50-day SMA: 27.25 Sell
200-day SMA: 26.2 Sell
8-day EMA: 24.1 Sell
20-day EMA: 26.01 Sell
50-day EMA: 26.96 Sell
200-day EMA: 24.96 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 252.75 Sell
20-day SMA: 267.61 Sell
50-day SMA: 273.13 Sell
200-day SMA: 210.87 Buy
8-day EMA: 250.09 Sell
20-day EMA: 262.36 Sell
50-day EMA: 266.92 Sell
200-day EMA: 230.73 Buy

Dianthus Therapeutics Earnings Growth & DNTH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Dianthus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):